GM-CSF modulates pulmonary resistance to influenza A infection

Antiviral Research

Volumn 92, Issue 2, 2011, Pages 319-328

  Sever Chroneos, Zvjezdana ^a   Murthy, Aditi ^a   Davis, Jeremy ^a   Florence, Jon Matthew ^a   Kurdowska, Anna ^a   Krupa, Agnieszka ^a   Tichelaar, Jay W ^b   White, Mitchell R ^c   Hartshorn, Kevan L ^c   Kobzik, Lester ^e   Whitsett, Jeffrey A ^d   Chroneos, Zissis C ^a  

^a UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Alveolar macrophages; Epithelial cells; GM CSF; Influenza; Scavenger receptors; SP A

Indexed keywords

GLYCOPROTEIN P 15095; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; SCAVENGER RECEPTOR A; SURFACTANT PROTEIN C;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HOST RESISTANCE; IMMUNOMODULATION; INFLUENZA A; INFLUENZA VIRUS A H1N1; INTERSTITIAL PNEUMONIA; LUNG ALVEOLUS MACROPHAGE; LUNG HOMOGENATE; LUNG LAVAGE; LUNG RESISTANCE; MALE; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PUERTO RICO; TREATMENT OUTCOME; VIRUS STRAIN;

ANIMALS; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; INFLUENZA A VIRUS, H1N1 SUBTYPE; LUNG; LYMPHOCYTES; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; ORTHOMYXOVIRIDAE INFECTIONS; SURVIVAL ANALYSIS;

MUS;

EID: 80054860186     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2011.08.022     Document Type: Article

References (59)

1. Arora D.J., Tremblay P., Bourgault R., Boileau S. Concentration and purification of influenza virus from allantoic fluid. Anal. Biochem. 1985, 144:189-192.
2. Arredouani M.S., Yang Z., Imrich A., Ning Y., Qin G., Kobzik L. The macrophage scavenger receptor SR-AI/II and lung defense against pneumococci and particles. Am. J. Resp. Cell Mol. Biol. 2006, 35:474-478.
3. Baker A.D., Malur A., Barna B.P., Ghosh S., Kavuru M.S., Malur A.G., Thomassen M.J. Targeted PPAR{gamma} deficiency in alveolar macrophages disrupts surfactant catabolism. J. Lipid Res. 2010, 51:1325-1331.
4. Ballinger M.N., Paine R., Serezani C.H., Aronoff D.M., Choi E.S., Standiford T.J., Toews G.B., Moore B.B. Role of granulocyte macrophage colony-stimulating factor during Gram-negative lung infection with Pseudomonas aeruginosa. Am. J. Resp. Cell Molec. Biol.34 2006, 766-774.
5. Baskin C.R., Bielefeldt-Ohmann H., Tumpey T.M., Sabourin P.J., Long J.P., Garcia-Sastre A., Tolnay A.E., Albrecht R., Pyles J.A., Olson P.H., Aicher L.D., Rosenzweig E.R., Murali-Krishna K., Clark E.A., Kotur M.S., Fornek J.L., Proll S., Palermo R.E., Sabourin C.L., Katze M.G. Early and sustained innate immune response defines pathology and death in nonhuman primates infected by highly pathogenic influenza virus. Proc. Natl. Acad. Sci. USA 2009, 106:3455-3460.
6. Belisle S.E., Tisoncik J.R., Korth M.J., Carter V.S., Proll S.C., Swayne D.E., Pantin-Jackwood M., Tumpey T.M., Katze M.G. Genomic profiling of tumor necrosis factor alpha (TNF-alpha) receptor and interleukin-1 receptor knockout mice reveals a link between TNF-alpha signaling and increased severity of 1918 pandemic influenza virus infection. J. Virol. 2010, 84:12576-12588.
7. Benne C.A., Benaissa-Trouw B., van Strijp J.A., Kraaijeveld C.A., van Iwaarden J.F. Surfactant protein A, but not surfactant protein D, is an opsonin for influenza A virus phagocytosis by rat alveolar macrophages. Eur. J. Immunol. 1997, 27:886-890.
8. Berclaz P.Y., Carey B., Fillipi M.D., Wernke-Dollries K., Geraci N., Cush S., Richardson T., Kitzmiller J., O'Connor M., Hermoyian C., Korfhagen T., Whitsett J.A., Trapnell B.C. GM-CSF regulates a PU.1-dependent transcriptional program determining the pulmonary response to LPS. Am. J. Resp. Cell Mol. Biol. 2007, 36:114-121.
9. Biwa T., Hakamata H., Sakai M., Miyazaki A., Suzuki H., Kodama T., Shichiri M., Horiuchi S. Induction of murine macrophage growth by oxidized low density lipoprotein is mediated by granulocyte macrophage colony-stimulating factor. J. Biol. Chem. 1998, 273:28305-28313.
10. Burgess A.W., Camakaris J., Metcalf D. Purification and properties of colony-stimulating factor from mouse lung-conditioned medium. J. Biol. Chem. 1977, 252:1998-2003.
11. Cakarova L., Marsh L.M., Wilhelm J., Mayer K., Grimminger F., Seeger W., Lohmeyer J., Herold S. Macrophage tumor necrosis factor-alpha induces epithelial expression of granulocyte-macrophage colony-stimulating factor: impact on alveolar epithelial repair. Am. J. Respir. Crit. Care Med. 2009, 180:521-532.
12. Carey B., Trapnell B.C. The molecular basis of pulmonary alveolar proteinosis. Clin. Immunol. 2010, 135:223-235.
13. Chroneos Z.C., Midde K., Sever-Chroneos Z., Jagannath C. Pulmonary surfactant and tuberculosis. Tuberculosis 2009, 89(Suppl. 1):S10-14.
14. DeWitte-Orr S.J., Collins S.E., Bauer C.M., Bowdish D.M., Mossman K.L. An accessory to the 'Trinity': SR-As are essential pathogen sensors of extracellular dsRNA, mediating entry and leading to subsequent type I IFN responses. PLoS Path. 2010, 6:e1000829. 10.1371/journal.ppat.1000829.
15. Dranoff G., Crawford A.D., Sadelain M., Ream B., Rashid A., Bronson R.T., Dickersin G.R., Bachurski C.J., Mark E.L., Whitsett J.A., et al. Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis. Science 1994, 264:713-716.
16. Fleetwood A.J., Dinh H., Cook A.D., Hertzog P.J., Hamilton J.A. GM-CSF- and M-CSF-dependent macrophage phenotypes display differential dependence on type I interferon signaling. J. leuk. Biol. 2009, 86:411-421.
17. Fukushi M., Ito T., Oka T., Kitazawa T., Miyoshi-Akiyama T., Kirikae T., Yamashita M., Kudo K. Serial histopathological examination of the lungs of mice infected with influenza A virus PR8 strain. PloS one 2011, 6:e21207. 10.1371/journal.pone.0021207.
18. Ghosh S., Gregory D., Smith A., Kobzik L. MARCO regulates early inflammatory responses against influenza: a useful macrophage function with adverse outcome. Am. J. Resp. Crit. Care Med. 2011, (Epub ahead of print). 10.1165/rcmb.2010-0349O.
19. Gossen M., Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. USA 1992, 89:5547-5551.
20. Haisma H.J., Boesjes M., Beerens A.M., van der Strate B.W., Curiel D.T., Pluddemann A., Gordon S., Bellu A.R. Scavenger receptor A: a new route for adenovirus 5. Mol. Pharm. 2009, 6:366-374.
21. Hamilton J.A. Colony-stimulating factors in inflammation and autoimmunity. Nat. Rev. Immunol. 2008, 8:533-544.
22. Hartshorn K.L., Collamer M., Auerbach M., Myers J.B., Pavlotsky N., Tauber A.I. Effects of influenza A virus on human neutrophil calcium metabolism. J. Immunol. 1988, 141:1295-1301.
23. Hartshorn K.L., White M.R., Shepherd V., Reid K., Jensenius J.C., Crouch E.C. Mechanisms of anti-influenza activity of surfactant proteins A and D: comparison with serum collectins. Am. J. Physiol. 1997, 273:L1156-1166.
24. Hawgood S., Brown C., Edmondson J., Stumbaugh A., Allen L., Goerke J., Clark H., Poulain F. Pulmonary collectins modulate strain-specific influenza a virus infection and host responses. J. Virol. 2004, 78:8565-8572.
25. Hennet T., Ziltener H.J., Frei K., Peterhans E. A kinetic study of immune mediators in the lungs of mice infected with influenza A virus. J. Immuno. 1992, 1(149):932-939.
26. Herbert A.S., Heffron L., Sundick R., Roberts P.C. Incorporation of membrane-bound, mammalian-derived immunomodulatory proteins into influenza whole virus vaccines boosts immunogenicity and protection against lethal challenge. Virol. J. 2009, 6:42.
27. Herold S., Steinmueller M., von Wulffen W., Cakarova L., Pinto R., Pleschka S., Mack M., Kuziel W.A., Corazza N., Brunner T., Seeger W., Lohmeyer J. Lung epithelial apoptosis in influenza virus pneumonia: the role of macrophage-expressed TNF-related apoptosis-inducing ligand. J. Exp. Med. 2008, 205:3065-3077.
28. Huang F.F., Barnes P.F., Feng Y., Donis R., Chroneos Z.C., Idell S., Allen T., Perez D.R., Whitsett J.A., Dunussi-Joannopoulos K., Shams H. GM-CSF in the lung protects against lethal influenza infection. Am. J. Resp. Crit. Care Med. 2011, (Epub Ahead of Print). 10.1164/rccm.201012-2036O.
29. Huang H., Li H., Zhou P., Ju D. Protective effects of recombinant human granulocyte macrophage colony stimulating factor on H1N1 influenza virus-induced pneumonia in mice. Cytokine 2010, 51:151-157.
30. Huffman J.A., Hull W.M., Dranoff G., Mulligan R.C., Whitsett J.A. Pulmonary epithelial cell expression of GM-CSF corrects the alveolar proteinosis in GM-CSF-deficient mice. J. Clin. Invest. 1996, 97:649-655.
31. Huffman Reed J.A., Rice W.R., Zsengeller Z.K., Wert S.E., Dranoff G., Whitsett J.A. GM-CSF enhances lung growth and causes alveolar type II epithelial cell hyperplasia in transgenic mice. Am. J. Physiol. 1997, 273:L715-L725.
32. Job E.R., Deng Y.M., Tate M.D., Bottazzi B., Crouch E.C., Dean M.M., Mantovani A., Brooks A.G., Reading P.C. Pandemic H1N1 influenza A viruses are resistant to the antiviral activities of innate immune proteins of the collectin and pentraxin superfamilies. J. Immunol. 2010, 185:4284-4291.
33. Jozefowski S., Sulahian T.H., Arredouani M., Kobzik L. Role of scavenger receptor MARCO in macrophage responses to CpG oligodeoxynucleotides. J. Leuk. Biol. 2006, 80:870-879.
34. Kilbourne E.D. Influenza pandemics of the 20th century. Em. Infect. Dis. 2006, 12:9-14.
35. La Gruta N.L., Rothwell W.T., Cukalac T., Swan N.G., Valkenburg S.A., Kedzierska K., Thomas P.G., Doherty P.C., Turner S.J. Primary CTL response magnitude in mice is determined by the extent of naive T cell recruitment and subsequent clonal expansion. J. Clin. Invest. 2010, 120:1885-1894.
36. Loudon, P.T., Yager, E.J., Lynch, D.T., Narendran, A., Stagnar, C., Franchini, A.M., Fuller, J.T., White, P.A., Nyuandi, J., Wiley, C.A., Murphey-Corb, M., Fuller, D.H., 2010. GM-CSF increases mucosal and systemic immunogenicity of an H1N1 influenza DNA vaccine administered into the epidermis of non-human primates. PLoS One 5, e11021. Available from: <>http://www.ncbi.nlm.nih.gov/pubmed/20544035.
37. Mukhopadhyay S., Varin A., Chen Y., Liu B., Tryggvason K., Gordon S. SR-A/MARCO-mediated ligand delivery enhances intracellular TLR and NLR function, but ligand scavenging from cell surface limits TLR4 response to pathogens. Blood 2011, 117:1319-1328.
38. Paine R., Morris S.B., Jin H., Wilcoxen S.E., Phare S.M., Moore B.B., Coffey M.J., Toews G.B. Impaired functional activity of alveolar macrophages from GM-CSF-deficient mice. Am. J. Physiol. Lung Cell. Mol. Physiol 2001, 281:L1210-L1218.
39. Peiris J.S., Hui K.P., Yen H.L. Host response to influenza virus: protection versus immunopathology. Curr. Opin. Immunol. 2010, 22:475-481.
40. Pinsker K.L., Schneyer B., Becker N., Kamholz S.L. Usual interstitial pneumonia following Texas A2 influenza infection. Chest 1981, 80:123-126.
41. Reed J.A., Clegg D.J., Smith K.B., Tolod-Richer E.G., Matter E.K., Picard L.S., Seeley R.J. GM-CSF action in the CNS decreases food intake and body weight. J. Clin. Invest. 2005, 115:3035-3044.
42. Seimon T.A., Obstfeld A., Moore K.J., Golenbock D.T., Tabas I. Combinatorial pattern recognition receptor signaling alters the balance of life and death in macrophages. Proc Natl Acad Sci USA 2006, 103:19794-19799.
43. Sever-Chroneos Z., Krupa A., Davis J., Hasan M., Yang C.H., Szeliga J., Herrmann M., Hussain M., Geisbrecht B.V., Kobzik L., Chroneos Z.C. Surfactant protein A (SP-A)-mediated clearance of Staphylococcus aureus involves binding of SP-A to the staphylococcal adhesin eap and the macrophage receptors SP-A receptor 210 and scavenger receptor class A. J. Biol. Chem. 2011, 286:4854-4870.
44. Shibata Y., Berclaz P.Y., Chroneos Z.C., Yoshida M., Whitsett J.A., Trapnell B.C. GM-CSF regulates alveolar macrophage differentiation and innate immunity in the lung through PU. 1. Immunity 2001, 15:557-567.
45. Srivastava, B., Blazejewska, P., Hessmann, M., Bruder, D., Geffers, R., Mauel, S., Gruber, A.D., Schughart, K., 2009. Host genetic background strongly influences the response to influenza a virus infections. PloS One 4, e4857. Available from: <>http://www.ncbi.nlm.nih.gov/pubmed/19293935.
46. Sulahian, T.H., Imrich, A., Deloid, G., Winkler, A.R., Kobzik, L., 2008. Signaling pathways required for macrophage scavenger receptor-mediated phagocytosis: analysis by scanning cytometry. Resp. Res. 9, 59. Available from: <>http://www.ncbi.nlm.nih.gov/pubmed/18687123.
47. Szeliga J., Daniel D.S., Yang C.H., Sever-Chroneos Z., Jagannath C., Chroneos Z.C. Granulocyte-macrophage colony stimulating factor-mediated innate responses in tuberculosis. Tuberculosis 2008, 88:7-20.
48. Tate M.D., Pickett D.L., van Rooijen N., Brooks A.G., Reading P.C. Critical role of airway macrophages in modulating disease severity during influenza virus infection of mice. J. Virol. 2010, 84:7569-7580.
49. Taubenberger J.K., Morens D.M. Influenza: the once and future pandemic. Public Health Rep. 2010, 125(Suppl. 3):16-26.
50. Tazelaar H.D., Wright J.L., Churg A. Desquamative interstitial pneumonia. Histopathology 2011, 58:509-516.
51. Tumpey T.M., Garcia-Sastre A., Taubenberger J.K., Palese P., Swayne D.E., Pantin-Jackwood M.J., Schultz-Cherry S., Solorzano A., Van Rooijen N., Katz J.M., Basler C.F. Pathogenicity of influenza viruses with genes from the 1918 pandemic virus: functional roles of alveolar macrophages and neutrophils in limiting virus replication and mortality in mice. J. Virol. 2005, 79:14933-14944.
52. van Eijk M., White M.R., Crouch E.C., Batenburg J.J., Vaandrager A.B., Van Golde L.M., Haagsman H.P., Hartshorn K.L. Porcine pulmonary collectins show distinct interactions with influenza A viruses: role of the N-linked oligosaccharides in the carbohydrate recognition domain. J. Immunol. 2003, 171:1431-1440.
53. Wang J., Nikrad M.P., Phang T., Gao B., Alford T., Ito Y., Edeen K., Travanty E.A., Kosmider B., Hartshorn K., Mason R.J. Innate immune response to influenza A virus in differentiated human alveolar type II cells. Am. J. Resp. Crit. Care Med. 2011, (Epub Ahead of Print). 10.1165/rcmb.2010-0108O.
54. White M.R., Doss M., Boland P., Tecle T., Hartshorn K.L. Innate immunity to influenza virus: implications for future therapy. Expert. Rev. Clin. Immunol. 2008, 4:497-514.
55. Willinger T., Rongvaux A., Takizawa H., Yancopoulos G.D., Valenzuela D.M., Murphy A.J., Auerbach W., Eynon E.E., Stevens S., Manz M.G., Flavell R.A. Human IL-3/GM-CSF knock-in mice support human alveolar macrophage development and human immune responses in the lung. Proc. Natl. Acad. Sci. 2011, 108:2390-2395.
56. Winkler A.R., Nocka K.H., Sulahian T.H., Kobzik L., Williams C.M. In vitro modeling of human alveolar macrophage smoke exposure: enhanced inflammation and impaired function. Exp. Lung Res. 2008, 34:599-629.
57. Yoshimi N., Ikura Y., Sugama Y., Kayo S., Ohsawa M., Yamamoto S., Inoue Y., Hirata K., Itabe H., Yoshikawa J., Ueda M. Oxidized phosphatidylcholine in alveolar macrophages in idiopathic interstitial pneumonias. Lung 2005, 183:109-121.
58. Zhang J., Zhang Z., Fan X., Liu Y., Wang J., Zheng Z., Chen R., Wang P., Song W., Chen H., Guan Y. 2009 pandemic H1N1 influenza virus replicates in human lung tissues. J. Infect. Dis. 2010, 201:1522-1526.
59. Zhou, H., Imrich, A., Kobzik, L., 2008. Characterization of immortalized MARCO and SR-AI/II-deficient murine alveolar macrophage cell lines. Part. Fibre Toxicol. 5, 7 Available from: <>http://www.ncbi.nlm.nih.gov/pubmed/18452625.